Generic Drug Makers Agree to Pay a Combined $45 Million in Settlements to End Price-Fixing Litigation

Three generic drug makers agreed to pay a combined $45 million in settlements to put an end to claims they engaged in price-fixing a number of medications.

In three separate settlements, Apotex Corp. agreed to pay around $30 million, Heritage Pharmaceuticals Ltd. agreed to pay $10 million and Breckenridge Pharmaceuticals Inc. agreed to pay $5 million to end the claims.

The settlement amounts could ultimately increase or decrease based on the number of class members who either make a claim to join or choose to opt out of the agreements, according to requests for preliminary approval of the deals.

Read the source article at Top Class Actions